Author Archives: Guest Blogger

The Decline of Clinical Trials in Central and Eastern Europe

Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia.  The U.S. hosts 49% of clinical trial sites and generates approximately 40% of clinical data.  Other regions have arisen in recent years.  The main reasons behind this globalization trend are the availability of highly skilled professionals in new research markets, lower […]
Posted in Emerging Markets, Europe, Global, R&D | Tagged , , , , , | Leave a comment

Mastering the Language of Payers

By Sydney Rubin. The first rule of effective communications — whether speaking to a beloved offspring or an important customer — is to know your audience. We must understanding what motivates the listener, what they care about, what language will most likely persuade. Don’t expect an argument on the importance of retirement savings to convince […]
Posted in Guest Blog, Marketing, Op-Ed | Tagged , , , | Leave a comment

Making the Most of Social Media (Within FDA’s New Guidelines)

By Ken Ribotsky. Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into […]
Posted in compliance, E-Media, FDA, Guest Blog, Op-Ed, Regulatory, social media | Tagged , | 1 Comment

435 New Medicines in Development for “Older Americans”

By Melanie Sena. According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s biopharmaceutical research companies are developing 435 new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development include: 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 […]
Posted in healthcare, R&D | Tagged , , , , | Leave a comment

Key Clinical Trial Themes from DIA 2014

The Drug Information Association (DIA), one of the largest non-profit organizations supporting clinical research and drug development, held its 2014 annual meeting in San Diego last week. Applied Clinical Trials’ Moe Alsumidaie looks at three of the key themes from this year’s meeting: incorporating advocacy groups and patient voices in clinical research, breakthrough research applications, and […]
Posted in Events, Global, Guest Blog, Meetings, R&D, Technology | Tagged , , , , , | Leave a comment
  • Categories

  • Meta